4Salzman D, Tami J, Jackson C, et al.Clincial remission of myasthenia gravis in a patient after high dose therapy and autologus transplantation with CD+34 stem cell. Blood,1994,84(suppl):206a.
5Pasquini MC,Wang Z.Current use and outcome of Hematopoietic stem cell transplantation[R/L].USA:Center for International Blood and Marrow Transplant Research(CIBMTR),2010.
6Koh LP,Hwang WY,Tan CH,et al.Long term follow-up of Asian patients with chronic myeloid leukemia(CML)receiving allogeneic hematopoietic stem cell transplantation(HSCT)from HLA-identical sibling-evalution of risks and benefits[J].Ann Hematol,2004,83:286-294.
7Vander Straaten HM,Fijnheer R,Dekker AW,et al.Relationship between graft-versus-host disease and graftversus-leukemia in partial T cell-depleted bone marrow transplantation[J].British Journal of Haematology,2001,114(1):31-35.
8Anderlini P,Rizzo JD,Nugent ML,et al.Peripheral blood stem cell donation:an analysis from the International Bone Marrow Transplant Registry(IBMTR)and European Group for Bloodand Marrow Transplant(EBMT)databases[J].Bone Marrow Transplant,2001,27(7):689-692.
9Lazarus HM,Vogelsang GB,Rowe JM,et al.Prevention and treatment of acute graft-versus-host disease:the old and the new[J].Bone Marrow Transplantation,1997,19(6):577.
10Champlin RE,Schmitz N,Mary M,et al.Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation[J].Blood,2000,95(12):3.
